Mastek, a leading digital engineering and cloud transformation company, has announced a strategic partnership with Zulekha Healthcare Group, one of the largest private healthcare providers in the UAE. The collaboration aims to enhance Zulekha’s operations by implementing Oracle Fusion Cloud solutions integrated with Oracle Health (Cerner).
This digital upgrade supports Zulekha’s “Patient First” approach. The new system will help improve clinical workflows, boost operational efficiency, increase financial agility, and reduce manual processes. It will also strengthen regulatory compliance and support better decision-making through data insights.
Read More, Anand Rathi Wealth Declared Final Dividend: Set May 9 as Record Date.
Zulekha Healthcare is a well-known healthcare group in the UAE, employing over 2,500 people including 300+ doctors and 600+ nurses. The group runs 2 hospitals with a total of 285 beds, offering a wide range of medical and surgical treatments. It also manages a smart medical fitness centre for services like visa medicals, vaccinations, and health certifications.
Zulekha selected Mastek due to its global reputation as a trusted Oracle partner and its expertise in healthcare digital solutions. Mastek has completed over 1,500 Oracle Cloud implementations in 40+ countries and offers more than 100 industry-specific solutions. With a team of over 2,000 skilled consultants, Mastek will fully integrate the new Oracle Cloud system with Zulekha’s existing hospital management and revenue systems.
Taher Shams, Managing Director of Zulekha Healthcare Group, said, “Our partnership with Mastek is a big step in our digital journey. The Oracle Fusion Cloud will help us become more agile, make smarter decisions, and ensure strong data security for better patient care.”
Mastek is a global company that delivers enterprise AI, digital, and cloud solutions, helping clients get long-term value from their technology investments. With a presence in over 40 countries and a team of 5,000+ professionals, Mastek works with major technology partners like Oracle, Salesforce, Microsoft, AWS, Snowflake, and Databricks.
As of 1:09 PM IST on May 8, Mastek share price is trading at ₹2,180.90, up ₹86.50 or 4.13% for the day. The stock opened at ₹2,100.00, hit an intraday high of ₹2,223.00 and a low of ₹2,091.00. Mastek has a market capitalisation of ₹6,750 crore and a price-to-earnings (P/E) ratio of 18.08. The stock’s 52-week high is ₹3,375.00, while the 52-week low stands at ₹1,887.00.
Zulekha Healthcare Group is one of the top-ranked healthcare providers in the UAE and has been recognised by Newsweek as one of the World’s Best Hospitals. The group runs two major hospitals in Dubai and Sharjah, along with several medical centres and pharmacies.
This collaboration between Mastek and Zulekha Healthcare marks a significant milestone in healthcare innovation in the UAE. By embracing advanced Oracle Cloud technologies and streamlining systems, Zulekha is setting new standards in delivering efficient, secure, and patient-centric care. This partnership reflects the growing trend of digital transformation in the healthcare sector aimed at enhancing operational excellence and patient outcomes.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities market are subject to market risks, read all the related documents carefully before investing.
Published on: May 8, 2025, 1:14 PM IST
Kusum Kumari
Kusum Kumari is a Content Writer with 4 years of experience in simplifying financial market concepts. Currently crafting insightful content at Angel One, She specialise in breaking down complex topics into easy-to-understand pieces, blending expertise in market fundamentals and technical analysis.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates